Kantarjian H - Search Results

1

Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemia.

Strati P, Daver N, Ravandi F, Pemmaraju N, Pierce S, Garcia-Manero G, Nazha A, Kadia T, Jabbour E, Borthakur G, Faderl S, Quintas-Cardama A, Kantarjian H, Cortes J. Strati P, et al. Among authors: kantarjian h. Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2(0 2):S276-81. doi: 10.1016/j.clml.2013.05.020. Epub 2013 Aug 19. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23969309 Free PMC article.

2

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keating M. Estey E, et al. Among authors: kantarjian h. Blood. 1992 May 1;79(9):2246-55. Blood. 1992. PMID: 1571541 Free article.

3

Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.

Keating MJ, Estey E, Kantarjian H, Plunkett W, O'Brien S, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. Leukemia. 1992;6 Suppl 2:78-80. Leukemia. 1992. PMID: 1578950 Review. No abstract available.

4

Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M. Dhingra K, et al. Among authors: kantarjian h. Leukemia. 1992 Aug;6(8):754-60. Leukemia. 1992. PMID: 1640725

5

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.

O'Brien S, Kantarjian H, Estey E, Koller C, Beran M, McCredie K, Keating M. O'Brien S, et al. Among authors: kantarjian h. Cancer. 1991 Aug 15;68(4):691-4. doi: 10.1002/1097-0142(19910815)68:4<691::aid-cncr2820680404>3.0.co;2-z. Cancer. 1991. PMID: 1855168

6

Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.

Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R. Dhingra K, et al. Among authors: kantarjian h. Leukemia. 1991 Mar;5(3):191-5. Leukemia. 1991. PMID: 2013978

7

Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.

Beran M, Andersson B, Kantarjian H, Keating M, Rios A, McCredie KB, Freireich EJ, Gutterman J. Beran M, et al. Among authors: kantarjian h. Leukemia. 1987 Jan;1(1):52-7. Leukemia. 1987. PMID: 2444829

8

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. J Clin Oncol. 1989 Aug;7(8):1071-80. doi: 10.1200/JCO.1989.7.8.1071. J Clin Oncol. 1989. PMID: 2666590

9

Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.

Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. Leukemia. 1988 Jul;2(7):403-12. Leukemia. 1988. PMID: 3164797

10

Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.

Schachner J, Kantarjian H, Dalton W, McCredie K, Keating M, Freireich EJ. Schachner J, et al. Among authors: kantarjian h. Leukemia. 1988 Oct;2(10):667-71. Leukemia. 1988. PMID: 3172842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,546 results

Search Page

Filters